T1	Condition 0 9	Psoriasis
T3	Condition 13 34	psoriasis arthropathy
*	OR T1 T3
T2	Condition 36 62	Inflammatory bowel disease
T4	Informed_consent 64 139	Unwillingness to participate in the study with additional imaging protocols
T5	Observation 141 159	Expected life-span
T6	Value 160 177	less than <1 year
R1	Has_value Arg1:T5 Arg2:T6	
T7	Condition 179 187	Diabetes
T8	Procedure 204 223	PET imaging quality
T9	Qualifier 226 234	Probable
T10	Condition 235 248	noncompliance
R2	Has_qualifier Arg1:T10 Arg2:T9	
T11	Condition 250 259	Pregnancy
T12	Person 261 264	Age
T13	Value 265 274	<18 years
T14	Value 278 287	>75 years
*	OR T13 T14
T15	Scope 265 287	<18 years or >75 years
R3	Has_scope Arg1:T12 Arg2:T15	
T16	Condition 289 305	Contraindication
T17	Drug 310 320	adalimumab
R4	AND Arg1:T16 Arg2:T17	
T18	Drug 322 334	Methotrexate
T19	Temporal 340 368	within the previous 6 months
R5	Has_temporal Arg1:T18 Arg2:T19	
T20	Drug 372 389	biologic medicine
T21	Temporal 395 423	within the previous 6 months
R6	Has_temporal Arg1:T20 Arg2:T21	
